Sylentis receives approval to begin phase I studies with its antiglaucoma agent SYL-040012 July 27, 2009 No Comments
Foresight reports results from a pilot study of FST-100 in viral conjunctivitis July 23, 2009 No Comments
Foresight presents preclinical FST-100 data from adenoviral conjunctivitis model July 13, 2009 No Comments
RSS